Overview

Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention

Status:
Not yet recruiting
Trial end date:
2027-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to test the efficacy of the two long-acting thiazide-like diuretics indapamide and chlorthalidone in reducing urine supersaturation for calcium oxalate and calcium phosphate compared to the short-acting thiazide diuretic hydrochlorothiazide for the prevention of calcium-containing kidney stones.
Phase:
Phase 2
Details
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborator:
University of Bern
Treatments:
Chlorthalidone
Hydrochlorothiazide
Indapamide